Analyst firms · BofA Securities · JNJ
BofA Securities JNJ price target and rating history
Johnson & Johnson (JNJ) · Health Care
BofA Securities rates Johnson & Johnson (JNJ) Neutral with a $166 price target, as of its latest action on Dec 10, 2024. It has published 3 rating actions on JNJ since March 2022, including 0 upgrades and 0 downgrades. Across 4 firms with a JNJ price target in the last 12 months, the median target is $263.50.
- Current rating
- Neutral
- Price target
- $166
- Median target, all firms
- $263.50
- Actions on JNJ
- 3
BofA Securities price target on JNJ
Every BofA Securities rating on JNJ
- Dec 10, 2024
- Oct 14, 2022
- Mar 2, 2022
How other firms rate JNJ
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Erste Group | Hold | Oct 21, 2026 | |
| UBS | Buy | $320 | Sep 2, 2026 |
| Leerink Partners | Outperform | $265 | May 13, 2026 |
| TD Cowen | Buy | $250 | Apr 8, 2026 |
| Morgan Stanley | Overweight | $262 | Jan 28, 2026 |
Questions about BofA Securities and JNJ
- What is BofA Securities's price target for JNJ?
- BofA Securities's latest stated price target for Johnson & Johnson (JNJ) is $166, from its action on Dec 10, 2024.
- What is BofA Securities's rating on JNJ?
- BofA Securities rates JNJ Neutral, a neutral rating, as of Dec 10, 2024.
- When did BofA Securities last change its view on JNJ?
- On Dec 10, 2024, BofA Securities resumes coverage at Neutral, price target $166.
- How does BofA Securities's JNJ target compare with other analysts?
- Across 4 firms with a JNJ price target in the last 12 months, the median target is $263.50.
More JNJ rating histories
All BofA Securities ratingsJNJ news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.